Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2341 of 3330
Next
>>
>
58501 to 58525 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MDA-MB-361	HER2amp	Luminal	PD 98059	MEK	MAPK	0.000128	uM	12379.152	0.9716	0.8940	0.5297
MDA-MB-361	HER2amp	Luminal	PD 98059	MEK	MAPK	0.00064	uM	12379.152	1.0387	1.1486	0.5297
MDA-MB-361	HER2amp	Luminal	PD 98059	MEK	MAPK	0.0032	uM	12379.152	0.9278	0.7363	0.5297
MDA-MB-361	HER2amp	Luminal	PD 98059	MEK	MAPK	0.016	uM	12379.152	1.0029	1.0110	0.5297
MDA-MB-361	HER2amp	Luminal	PD 98059	MEK	MAPK	0.08	uM	12379.152	1.0446	1.1716	0.5297
MDA-MB-361	HER2amp	Luminal	PD 98059	MEK	MAPK	0.4	uM	12379.152	1.0299	1.1144	0.5297
MDA-MB-361	HER2amp	Luminal	PD 98059	MEK	MAPK	2	uM	12379.152	1.0021	1.0078	0.5297
MDA-MB-361	HER2amp	Luminal	PD 98059	MEK	MAPK	10	uM	12379.152	0.9619	0.8587	0.5297
MDA-MB-361	HER2amp	Luminal	PD 98059	MEK	MAPK	50	uM	12379.152	0.9020	0.6460	0.5297
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	0.000128	uM	10938.152	0.6373	0.2447	0.9498
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	0.00064	uM	10938.152	0.8430	0.6709	0.9498
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	0.0032	uM	10938.152	0.6815	0.3356	0.9498
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	0.016	uM	10938.152	0.9897	0.9783	0.9498
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	0.08	uM	10938.152	0.4206	-0.1965	0.9498
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	0.4	uM	10938.152	0.8481	0.6815	0.9498
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	2	uM	10938.152	0.9212	0.8345	0.9498
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	10	uM	10938.152	0.9233	0.8388	0.9498
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	50	uM	10938.152	0.8253	0.6339	0.9498
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	0.000128	uM	12333.152	0.9160	0.7754	0.7371
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	0.00064	uM	12333.152	0.9256	0.8008	0.7371
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	0.0032	uM	12333.152	1.0108	1.0293	0.7371
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	0.016	uM	12333.152	0.9149	0.7727	0.7371
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	0.08	uM	12333.152	0.9959	0.9889	0.7371
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	0.4	uM	12333.152	0.9174	0.7792	0.7371
MDA-MB-415	HR+	Luminal	PD 98059	MEK	MAPK	2	uM	12333.152	0.9503	0.8663	0.7371

|<
<<
Previous
Page 2341 of 3330
Next
>>
>
58501 to 58525 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)